Growth Metrics

Bio-Techne (TECH) EBT Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.59%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -148.28%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -313.33%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 71.54%
7 Evaxion A 62.56 Bn 62.54 Bn - -79.57%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.15%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 9,460.35%
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn 86.09%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 86.09%
Dec 31, 2025 18.44%
Sep 30, 2025 19.47%
Jun 30, 2025 -456.34%
Mar 31, 2025 -37.34%
Dec 31, 2024 28.42%
Sep 30, 2024 -18.94%
Jun 30, 2024 -65.15%
Mar 31, 2024 -23.83%
Dec 31, 2023 -49.74%
Sep 30, 2023 -52.22%
Jun 30, 2023 11.72%
Mar 31, 2023 16.61%
Dec 31, 2022 -22.92%
Sep 30, 2022 53.92%
Jun 30, 2022 274.12%
Mar 31, 2022 51.63%
Dec 31, 2021 52.89%
Sep 30, 2021 71.29%
Jun 30, 2021 -173.79%
Mar 31, 2021 -3.13%
Dec 31, 2020 -62.50%
Sep 30, 2020 120.93%
Jun 30, 2020 170.01%
Mar 31, 2020 -6.13%
Dec 31, 2019 590.61%
Sep 30, 2019 1.25%
Jun 30, 2019 190.11%
Mar 31, 2019 99.65%
Dec 31, 2018 0.17%
Sep 30, 2018 -23.43%
Jun 30, 2018 -166.81%
Mar 31, 2018 -19.78%
Dec 31, 2017 43.08%
Sep 30, 2017 -17.34%
Jun 30, 2017 262.42%
Mar 31, 2017 -26.71%
Dec 31, 2016 -57.06%
Sep 30, 2016 -12.75%
Jun 30, 2016 78.67%
Mar 31, 2016 9.63%
Dec 31, 2015 -16.89%
Sep 30, 2015 -7.95%
Jun 30, 2015 106.62%
Mar 31, 2015 -15.87%
Dec 31, 2014 17.52%
Sep 30, 2014 -12.75%
Jun 30, 2014 -316.44%
Mar 31, 2014 3.61%
Dec 31, 2013 -3.28%
Sep 30, 2013 4.39%
Jun 30, 2013 0.36%
Mar 31, 2013 2.92%
Dec 31, 2012 -1.13%
Sep 30, 2012 -6.21%
Jun 30, 2012 146.10%
Mar 31, 2012 -4.80%
Dec 31, 2011 0.53%
Sep 30, 2011 3.97%
Jun 30, 2011 -2.14%
Mar 31, 2011 9.52%
Dec 31, 2010 2.65%
Sep 30, 2010 -1.90%